Literature DB >> 25957385

Identification of AKB-48 and 5F-AKB-48 Metabolites in Authentic Human Urine Samples Using Human Liver Microsomes and Time of Flight Mass Spectrometry.

Svante Vikingsson1, Martin Josefsson2, Henrik Gréen3.   

Abstract

The occurrence of structurally related synthetic cannabinoids makes the identification of unique markers of drug intake particularly challenging. The aim of this study was to identify unique and abundant metabolites of AKB-48 and 5F-AKB-48 for toxicological screening in urine. Investigations of authentic urine samples from forensic cases in combination with human liver microsome (HLM) experiments were used for identification of metabolites. HLM incubations of AKB-48 and 5F-AKB-48 along with 35 urine samples from authentic cases were analyzed with liquid chromatography quadrupole tandem time of flight mass spectrometry. Using HLMs 41 metabolites of AKB-48 and 37 metabolites of 5F-AKB-48 were identified, principally represented by hydroxylation but also ketone formation and dealkylation. Monohydroxylated metabolites were replaced by di- and trihydroxylated metabolites within 30 min. The metabolites from the HLM incubations accounted for on average 84% (range, 67-100) and 91% (range, 71-100) of the combined area in the case samples for AKB-48 and 5F-AKB-48, respectively. While defluorinated metabolites accounted for on average 74% of the combined area after a 5F-AKB-48 intake only a few identified metabolites were shared between AKB-48 and 5F-AKB-48, illustrating the need for a systematic approach to identify unique metabolites. HLMs in combination with case samples seem suitable for this purpose.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25957385     DOI: 10.1093/jat/bkv045

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  11 in total

1.  In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201).

Authors:  Xingxing Diao; Jeremy Carlier; Mingshe Zhu; Shaokun Pang; Robert Kronstrand; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Forensic Toxicol       Date:  2016-07-06       Impact factor: 4.096

2.  Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans.

Authors:  Shimpei Watanabe; Unnikrishnan Kuzhiumparambil; My Ann Nguyen; Jane Cameron; Shanlin Fu
Journal:  AAPS J       Date:  2017-04-28       Impact factor: 4.009

3.  Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.

Authors:  Isabella Canazza; Andrea Ossato; Claudio Trapella; Anna Fantinati; Maria Antonietta De Luca; Giulia Margiani; Fabrizio Vincenzi; Claudia Rimondo; Fabiana Di Rosa; Adolfo Gregori; Katia Varani; Pier Andrea Borea; Giovanni Serpelloni; Matteo Marti
Journal:  Psychopharmacology (Berl)       Date:  2016-08-15       Impact factor: 4.530

4.  Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity.

Authors:  Anna Pinson; Azure L Yarbrough; John M Bush; Christian V Cabanlong; Amal Shoeib; Bailey K Jackson; Saki Fukuda; Jyoti Gogoi; William E Fantegrossi; Keith McCain; Paul L Prather; Ryoichi Fujiwara; Anna Radominska-Pandya
Journal:  Pharmacol Biochem Behav       Date:  2020-05-13       Impact factor: 3.533

5.  Analytical Methodologies for the Characterization and Analysis of the Parent Compound and Phase I Metabolites of 4F-MDMB-BICA in Human Microsome, Urine, and Blood Samples.

Authors:  Tímea Körmöczi; Éva Sija; László Institóris; Éva M Kereszty; István Ilisz; Róbert Berkecz
Journal:  J Anal Toxicol       Date:  2021-01-06       Impact factor: 3.367

6.  In Vitro Inhibitory Effects of APINACA on Human Major Cytochrome P450, UDP-Glucuronosyltransferase Enzymes, and Drug Transporters.

Authors:  Sunjoo Kim; Won-Gu Choi; Mihwa Kwon; Sowon Lee; Yong-Yeon Cho; Joo Young Lee; Han Chang Kang; Im-Sook Song; Hye Suk Lee
Journal:  Molecules       Date:  2019-08-19       Impact factor: 4.411

7.  Pharmacological and Behavioral Effects of the Synthetic Cannabinoid AKB48 in Rats.

Authors:  Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Serena Stopponi; Laura Soverchia; Roberto Ciccocioppo; Paolo Frisoni; Sabina Strano-Rossi; Cristina Miliano; Fabio De-Giorgio; Giovanni Serpelloni; Anna Fantinati; Maria Antonietta De Luca; Margherita Neri; Matteo Marti
Journal:  Front Neurosci       Date:  2019-10-30       Impact factor: 4.677

8.  Screening, quantification, and confirmation of synthetic cannabinoid metabolites in urine by UHPLC-QTOF-MS.

Authors:  Per Ole M Gundersen; Olav Spigset; Martin Josefsson
Journal:  Drug Test Anal       Date:  2018-09-08       Impact factor: 3.345

9.  Metabolic Profiling of a CB2 Agonist, AM9338, Using LC-MS and Microcoil-NMR: Identification of a Novel Dihydroxy Adamantyl Metabolite.

Authors:  Chandrashekhar Honrao; Xiaoyu Ma; Shashank Kulkarni; Vinit Joshi; Michael Malamas; Alexander Zvonok; JodiAnne Wood; David Strand; Jason J Guo; Alexandros Makriyannis
Journal:  Front Pharmacol       Date:  2020-09-30       Impact factor: 5.810

10.  Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative Kinetics.

Authors:  Anna O Pinson; Dakota L Pouncey; Mary A Schleiff; William E Fantegrossi; Paul L Prather; Anna Radominska-Pandya; Gunnar Boysen; Grover P Miller
Journal:  Molecules       Date:  2020-10-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.